Oncothyreon to present at BioCentury NewsMakers Conference

About this update from Cascade Copper Corp.

[{"type":"text","content":"\n\n\n\nSEATTLE, Sept. 10 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY)\nannounced today that Robert Kirkman, M.D., President and Chief Executive\nOfficer, will present at the 16th Annual BioCentury NewsMakers in the Biotech\nIndustry Conference on Sept. 16, 2009 in New York.\n\n\nDr. Kirkman will present at 3 p.m. Eastern Time. A live and archived\nwebcast of the presentation will be accessible by visiting the Oncothyreon\nwebsite www.oncothyreon.com under the "News & Events" section.\n\n\nThe NewsMakers Conference is designed to stimulate interest in a select\ngroup of public biotech companies and is recognized as a key venue for\nreaching financial professionals including financial institutions,\npharmaceutical business development groups, and high net worth investors\nactive in the sector.\n\n\nAbout Oncothyreon\n\n\nOncothyreon is a biotechnology company specializing in the development of\ninnovative therapeutic products for the treatment of cancer. Oncothyreon's\ngoal is to develop and commercialize novel synthetic vaccines and targeted\nsmall molecules that have the potential to improve the lives and outcomes of\ncancer patients. For more information, visit www.oncothyreon.com.\n\n\n","length":1274,"tagName":"div"}]

More updates from Cascade Copper Corp.